Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis
Chiara Arena, Francesca Gado, Lorenzo Di Cesare Mannelli, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112858-112858
Open Access | Times Cited: 16

Showing 16 citing articles:

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay
Katharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski, et al.
Drug Testing and Analysis (2021) Vol. 13, Iss. 7, pp. 1402-1411
Closed Access | Times Cited: 32
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands
Francesca Gado, Rebecca Ferrisi, Beatrice Polini, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9918-9938
Open Access | Times Cited: 22
Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids
Philip Meier, Sandra Glasmacher, Anke Salmen, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis
Inés Reynoso-Moreno, Silvia Tietz, Erika Vallini, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 765-779
Open Access | Times Cited: 25
Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential
Valeria Gasperi, Tatiana Guzzo, Alessandra Topai, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 12, pp. 1420-1457
Closed Access | Times Cited: 18
Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile
Rebecca Ferrisi, Beatrice Polini, Anna Maria Smolyakova, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Reactive Astrocytosis in a Mouse Model of Chronic Polyamine Catabolism Activation
Chiara Cervetto, Monica Averna, Laura Vergani, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1274-1274
Open Access | Times Cited: 19
Neuronal alarmin IL-1α evokes astrocyte-mediated protective signals: Effectiveness in chemotherapy-induced neuropathic pain
Lorenzo Di Cesare Mannelli, Laura Micheli, Chiara Cervetto, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105716-105716
Open Access | Times Cited: 13
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
Rebecca Ferrisi, Beatrice Polini, Caterina Ricardi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2135-2135
Open Access | Times Cited: 7
Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
Beatrice Polini, Chiara Cervetto, Sara Carpi, et al.
Life (2020) Vol. 10, Iss. 12, pp. 333-333
Open Access | Times Cited: 19
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases
Rebecca Ferrisi, Costanza Ceni, Simone Bertini, et al.
Pharmacological Research (2021) Vol. 170, pp. 105607-105607
Open Access | Times Cited: 18
A systematic review of novel cannabinoids and their targets: insights into the significance of structure in activity
Mohammad Reza Abdollahzadeh Hamzekalayi, Mohammad Hooshyari Ardakani, Zahra Moeini, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176679-176679
Closed Access | Times Cited: 1
Carbon-silicon switch led to the discovery of novel synthetic cannabinoids with therapeutic effects in a mouse model of multiple sclerosis
Wenwen Duan, Ying Sun, Meng Wu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113878-113878
Closed Access | Times Cited: 6
Mechanisms Underlining Inflammatory Pain Sensitivity in Mice Selected for High and Low Stress-Induced Analgesia—The Role of Endocannabinoids and Microglia
Piotr Poznański, Joanna Giebułtowicz, Justyna Durdzinska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11686-11686
Open Access | Times Cited: 4
Advancing insights into vistas of novel drug delivery approaches for multiple sclerosis treatment-a review
Gadde Shareena, Dileep Kumar
Elsevier eBooks (2024), pp. 225-233
Closed Access
New cannabinoid receptor type 1 and 2 agonists and applications to understanding the endocannabinoid system: A chemical approach
Manuel Faúndez Parraguez
Elsevier eBooks (2023), pp. 397-416
Closed Access
Page 1

Scroll to top